Neoplasms, Colorectal Terminated Phase 3 Trials for Regorafenib (DB08896)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01939223Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudyTreatment